XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statement of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Preferred stock
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive (loss), net of tax
Treasury stock
Non-redeemable noncontrolling interests of consolidated investment management funds
Redeemable non- controlling interests/ temporary equity
Beginning Balance at Dec. 31, 2020 $ 45,944 [1] $ 4,541 $ 14 $ 27,823 $ 34,241 $ (985) $ (19,833) $ 143 $ 176
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued to shareholders of noncontrolling interests                 29
Redemption of subsidiary shares from noncontrolling interests                 (52)
Other net changes in noncontrolling interests 167     (24)       191 16
Net income (loss) 1,959       1,949     10  
Other comprehensive income (loss) (685)         (685)      
Other comprehensive income (loss) 0               0
Dividends:                  
Common stock (550)       (550)        
Preferred stock (100)       (100)        
Repurchase of common stock (1,317)           (1,317)    
Common stock issued under employee benefit plans 10     10          
Stock awards and options exercised 197     197          
Ending Balance at Jun. 30, 2021 45,625 [1],[2] 4,541 14 28,006 35,540 (1,670) (21,150) 344 169
Beginning Balance at Mar. 31, 2021 45,216 [2] 4,541 14 27,928 34,822 (1,819) (20,532) 262 187
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued to shareholders of noncontrolling interests                 6
Redemption of subsidiary shares from noncontrolling interests                 (22)
Other net changes in noncontrolling interests 86     9       77 (2)
Net income (loss) 1,027       1,022     5  
Other comprehensive income (loss) 149         149      
Other comprehensive income (loss) 0               0
Dividends:                  
Common stock [3] (273)       (273)        
Preferred stock (31)       (31)        
Repurchase of common stock (618)           (618)    
Common stock issued under employee benefit plans 5     5          
Stock awards and options exercised 64     64          
Ending Balance at Jun. 30, 2021 45,625 [1],[2] 4,541 14 28,006 35,540 (1,670) (21,150) 344 169
Beginning Balance at Dec. 31, 2021 43,230 [4],[5] 4,838 14 28,128 36,667 (2,213) (24,400) 196 161
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued to shareholders of noncontrolling interests                 7
Redemption of subsidiary shares from noncontrolling interests                 (14)
Other net changes in noncontrolling interests 5     (5)       10 4
Net income (loss) 765       773     (8)  
Other comprehensive income (loss) (1,668)         (1,668)      
Other comprehensive income (loss) (3)               (3)
Dividends:                  
Common stock [6] (278)       (278)        
Preferred stock (74)                
Preferred stock (74)       (74)        
Repurchase of common stock (118)           (118)    
Common stock issued under employee benefit plans 5     5          
Stock awards and options exercised 130     130          
Ending Balance at Mar. 31, 2022 41,997 [5],[7] 4,838 14 28,258 37,088 (3,881) (24,518) 198 155
Beginning Balance at Dec. 31, 2021 43,230 [4],[5] 4,838 14 28,128 36,667 (2,213) (24,400) 196 161
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued to shareholders of noncontrolling interests                 9
Redemption of subsidiary shares from noncontrolling interests                 (14)
Other net changes in noncontrolling interests (181)     (5)       (176) 4
Net income (loss) 1,629       1,642     (13)  
Other comprehensive income (loss) (3,094)         (3,094)      
Other comprehensive income (loss) (6)               (6)
Dividends:                  
Common stock [8] (557)       (557)        
Preferred stock (108)       (108)        
Repurchase of common stock (121)           (121)    
Common stock issued under employee benefit plans 10     10          
Preferred stock issued 0 0              
Stock awards and options exercised 183 [4]     183          
Ending Balance at Jun. 30, 2022 40,991 [7] 4,838 14 28,316 37,644 (5,307) (24,521) 7 154
Beginning Balance at Mar. 31, 2022 41,997 [5],[7] 4,838 14 28,258 37,088 (3,881) (24,518) 198 155
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued to shareholders of noncontrolling interests                 2
Other net changes in noncontrolling interests (186)     0       (186) 0
Net income (loss) 864       869     (5)  
Other comprehensive income (loss) (1,426)         (1,426)      
Other comprehensive income (loss) (3)               (3)
Dividends:                  
Common stock [9] (279)       (279)        
Preferred stock (34)       (34)        
Repurchase of common stock (3)           (3)    
Common stock issued under employee benefit plans 5     5          
Stock awards and options exercised 53     53          
Ending Balance at Jun. 30, 2022 $ 40,991 [7] $ 4,838 $ 14 $ 28,316 $ 37,644 $ (5,307) $ (24,521) $ 7 $ 154
[1] Includes total The Bank of New York Mellon Corporation common shareholders’ equity of $41,260 million at Dec. 31, 2020 and $40,740 million at June 30, 2021.
[2] Includes total The Bank of New York Mellon Corporation common shareholders’ equity of $40,413 million at March 31, 2021 and $40,740 million at June 30, 2021.
[3] Includes dividend-equivalents on share-based awards.
[4] Includes total The Bank of New York Mellon Corporation common shareholders’ equity of $38,196 million at Dec. 31, 2021 and $36,146 million at June 30, 2022.
[5] Includes total The Bank of New York Mellon Corporation common shareholders’ equity of $38,196 million at Dec. 31, 2021 and $36,961 million at March 31, 2022.
[6] Includes dividend-equivalents on share-based awards.
[7] Includes total The Bank of New York Mellon Corporation common shareholders’ equity of $36,961 million at March 31, 2022 and $36,146 million at June 30, 2022.
[8] Includes dividend equivalents on share-based awards.
[9] Includes dividend-equivalents on share-based awards.